DK14286A - Fremgangsmaade til fremstilling af steroider og mellemprodukter fremstillet ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af steroider og mellemprodukter fremstillet ved fremgangsmaaden Download PDF

Info

Publication number
DK14286A
DK14286A DK14286A DK14286A DK14286A DK 14286 A DK14286 A DK 14286A DK 14286 A DK14286 A DK 14286A DK 14286 A DK14286 A DK 14286A DK 14286 A DK14286 A DK 14286A
Authority
DK
Denmark
Prior art keywords
procedure
steroids
manufacture
intermediates produced
intermediates
Prior art date
Application number
DK14286A
Other languages
English (en)
Other versions
DK14286D0 (da
Inventor
Peter Max Smid
Willem Johan Van Zoest
Pieter Gijsbert Weber
Arthur Friedrich Marx
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of DK14286D0 publication Critical patent/DK14286D0/da
Publication of DK14286A publication Critical patent/DK14286A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK14286A 1985-01-14 1986-01-13 Fremgangsmaade til fremstilling af steroider og mellemprodukter fremstillet ved fremgangsmaaden DK14286A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85200022A EP0188010A1 (en) 1985-01-14 1985-01-14 New process for the preparation of certain steroids, especially intermediates for the preparation of proligestone and related compounds, and new intermediates formed in this process

Publications (2)

Publication Number Publication Date
DK14286D0 DK14286D0 (da) 1986-01-13
DK14286A true DK14286A (da) 1986-07-15

Family

ID=8193986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14286A DK14286A (da) 1985-01-14 1986-01-13 Fremgangsmaade til fremstilling af steroider og mellemprodukter fremstillet ved fremgangsmaaden

Country Status (12)

Country Link
US (1) US5093502A (da)
EP (2) EP0188010A1 (da)
JP (1) JPS61172896A (da)
AU (1) AU584158B2 (da)
CA (1) CA1321576C (da)
DE (1) DE3665721D1 (da)
DK (1) DK14286A (da)
ES (1) ES8707255A1 (da)
GR (1) GR860072B (da)
IE (1) IE58702B1 (da)
NZ (1) NZ214798A (da)
PT (1) PT81829B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6378196U (da) * 1986-11-10 1988-05-24
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
ATE230994T1 (de) * 1989-07-07 2003-02-15 Endorech Inc Methode zur behandlung androgenbedingter krankheiten
UA35589C2 (uk) * 1992-05-21 2001-04-16 Андорешерш Інк. ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20030022036A1 (en) * 2001-07-25 2003-01-30 Ballard Power Systems Inc. Fuel cell controller self inspection
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
RU2407800C1 (ru) * 2009-08-07 2010-12-27 Центр "Биоинженерия" РАН, ООО "НПК "СКиФФ" СПОСОБ ПОЛУЧЕНИЯ 14α-ГИДРОКСИПРОИЗВОДНЫХ Δ4-3,17-ДИКЕТО-АНДРОСТЕНОВ
CN104628806A (zh) * 2012-01-19 2015-05-20 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN106046099B (zh) * 2012-01-19 2018-03-16 华润紫竹药业有限公司 甾体化合物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3243355A (en) * 1965-07-30 1966-03-29 American Cyanamid Co Method of hydroxylating 19-nor-androstenedione
NL6703781A (da) * 1967-03-13 1968-09-16
US3812105A (en) * 1968-09-11 1974-05-21 Koninklijke Gist Spiritus 19-nor-progesterone derivatives
GB1277886A (en) * 1968-09-11 1972-06-14 Koninklijke Gist Spiritus Androstenones
US4585591A (en) * 1980-12-10 1986-04-29 Mitsubishi Chemical Industries, Ltd. 17β-ethynylsteroids and process for preparing same
US4557867A (en) * 1984-01-25 1985-12-10 The Upjohn Company 11β-Difluoromethyl and (E)- and (Z)-11-fluoromethylene steriods
US4600538A (en) * 1984-08-02 1986-07-15 The Upjohn Company Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes

Also Published As

Publication number Publication date
PT81829A (de) 1986-02-01
EP0189951A1 (en) 1986-08-06
US5093502A (en) 1992-03-03
DK14286D0 (da) 1986-01-13
ES8707255A1 (es) 1987-07-16
IE58702B1 (en) 1993-11-03
GR860072B (en) 1986-05-14
CA1321576C (en) 1993-08-24
EP0189951B1 (en) 1989-09-20
PT81829B (pt) 1987-11-30
NZ214798A (en) 1988-09-29
EP0188010A1 (en) 1986-07-23
DE3665721D1 (en) 1989-10-26
AU584158B2 (en) 1989-05-18
IE860088L (en) 1986-07-14
AU5225586A (en) 1986-07-17
JPS61172896A (ja) 1986-08-04
ES550862A0 (es) 1987-07-16

Similar Documents

Publication Publication Date Title
DK168985D0 (da) Fremgangsmaade til fremstilling af zeolit-beta
DK38385A (da) Fremgangsmaade til fremstilling af syntesegas
ES504340A0 (es) Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
DK169085D0 (da) Fremgangsmaade til fremstilling af zeolit-beta
DK14286D0 (da) Fremgangsmaade til fremstilling af steroider og mellemprodukter fremstillet ved fremgangsmaaden
DK129085D0 (da) Fremgangsmaade til fremstilling af proteiner
DK450686A (da) Fremgangsmaade til fremstilling af mordenitlegemer
DK99886A (da) Fremgangsmaade til fremstilling af baand af tofasestaal og staalbaand fremstillet ved fremgangsmaaden
DK75289A (da) Fremgangsmaade til fremstilling af antihypercholesterolemiske tetrazolforbindelser og mellemprodukter derved
DK143686D0 (da) Fremgangsmaade til fremstilling af metalsulfater
DK214585D0 (da) Fremgangsmaade til fremstilling af imidazorifamyciner
DK328280A (da) Fremgangsmaade til fremstilling af 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon og mellemprodukter herved
DK169386A (da) Fremgangsmaade til fremstilling af azetidinderivater og mellemprodukter dertil
DK422182A (da) Fremgangsmaade til intensivering af mikrobiologiske omdannelser af steroider
DK223783A (da) Fremgangsmaade til fremstilling af dihydropyridiner samt mellemprodukter til anvendelse ved fremgangsmaaden
DK232184D0 (da) Fremgangsmaade til fremstilling af 4-halogenmethylthiazoler og mellemprodukt til brug ved fremgangsmaaden
DK320780A (da) Fremgangsmaade og mellemprodukter til fremstilling af fluorerede methylaminoalkansyrer
DK223786A (da) Fremgangsmaade til omdannelse af ajle og produkter fremstillet ved fremgangsmaaden
DK312988A (da) Fremgangsmaade til fremstilling af zidovudin samt mellemprodukter ved fremgangsmaaden
DK559786D0 (da) Mellemprodukter til fremstilling af beta-lactamantibiotika
DK212284A (da) Fremgangsmaade til fremstilling af 20-keto-delta16-steroider og mellemprodukter dannet ved denne fremgangsmaade
DK547181A (da) Fremgangsmaade til fremstilling af halogenmethylestere af penicillansyresulfon og mellemprodukter ved fremgangsmaaden
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK509986A (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK326387D0 (da) Fremgangsmaade til demontering af konstruktioner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment